DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Omaxe Limited — Outcome of Board Meeting

NSE 2 hrs ago·27 Oct 2026, 11:23 am

Omaxe

Omaxe Limited has informed the stock exchanges that its board has approved the financial results for the period ending September 30, 2026. This filing is a routine regulatory requirement that signals the company's readiness to disclose its performance metrics to the public.

For investors, this update provides an early glimpse into the real estate developer's operational health and financial standing. The results will reveal how the company is managing its debt, cash flows, and project execution, which are critical factors for the sector.

Investors should monitor the specific figures for revenue growth, net profit, and debt levels. Positive trends could indicate recovery, while any deterioration might raise concerns about the company's liquidity and future expansion plans.